Company Description
Akumin Inc. (NASDAQ: AKU, TSX: AKU) is a prominent U.S.-based provider of comprehensive radiology and oncology services. Serving as a national partner of choice, Akumin collaborates with hospitals, health systems, and physician groups across 48 states, delivering state-of-the-art diagnostic and therapeutic services.
Akumin operates a robust network of 180 owned and/or operated imaging locations, providing a wide range of diagnostic imaging procedures such as MRI, CT, PET/CT, ultrasound, X-ray, mammography, and interventional radiology. Additionally, Akumin offers extensive oncology care, including a full suite of radiation therapy services.
In recent developments, Akumin reported significant financial milestones for the fiscal year ended December 31, 2022. The company achieved a revenue increase of 78% year-over-year, primarily driven by the acquisition of Alliance HealthCare Services. Despite a net loss of $151.6 million for the year, Akumin generated an adjusted EBITDA of $144.1 million, reflecting a substantial growth of 115% over the previous year.
Akumin has also been proactive in addressing industry challenges, such as clinical labor shortages and cost inflation. The company’s transformation initiatives, including site consolidations and operational restructuring, are expected to yield additional run-rate synergies exceeding $25 million in 2023.
Looking forward, Akumin remains focused on enhancing its service offerings and operational efficiency. The company's ongoing integration initiatives and technological advancements, such as the deployment of remote clinical capabilities, aim to deliver significant benefits and support organic growth in the coming years.
Recently, Akumin announced a financial restructuring plan backed by Stonepeak, an alternative investment firm. This plan, which involves a prepackaged chapter 11 process, is designed to strengthen Akumin's balance sheet and secure ample liquidity for future growth. Upon completion, Akumin will transition to a privately-held entity, further streamlining its operations and focusing on its strategic objectives.
Stock Performance
Latest News
SEC Filings
No SEC filings available for Akumin.